Skip to content

A Comparative Study of the Effective Optical Zone in Small Incision Corneal Lenticule Extraction Using VISUMAX 800 and VisuMax 500

A Comparative Study of the Effective Optical Zone in Small Incision Corneal Lenticule Extraction Using VISUMAX 800 and VisuMax 500

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126302
Enrollment
Unknown
Registered
2026-06-06
Start date
2026-06-10
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

VM800 group:SMILE surgery is performed using the VISUMAX 800 femtosecond laser device
VM500 group:SMILE surgery is performed using the VISUMAX 500 femtosecond laser device

Sponsors

Hangzhou Xihu Zhijiang Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-40 years, male or female; 2. Stable refractive error, with no more than 0.5D change within one year; 3. Corrected visual acuity >= 5.0; 4. Myopia below -10.00D, astigmatism below 5.00D; 5. Discontinued use of soft contact lenses for at least 1 week, rigid gas-permeable lenses for at least 3 weeks, or orthokeratology lenses for at least 3 months; 6. Residual corneal stromal thickness >280µm; 7. Able to comprehend the trial objectives, voluntarily participate, and provide signed informed consent by the patient or their legal guardian.

Exclusion criteria

Exclusion criteria: 1. Keratoconus or suspected keratoconus; 2. Complicated with other ocular diseases before surgery, such as severe dry eye, progressive or acute ophthalmic diseases; 3. Concurrent systemic diseases including systemic lupus erythematosus, connective tissue disorders, or psychiatric conditions; 4. Need for combined ophthalmic surgeries that may affect the results of this study; 5. Participation in other clinical trials of medical devices within 30 days prior to screening; 6. Pregnant or lactating women; 7. Other circumstances deemed ineligible by the investigator.

Design outcomes

Primary

MeasureTime frame
Effective Optical Zone;

Secondary

MeasureTime frame
Change in Q-value of the anterior corneal surface;Decentration value;Change in Q-value of the anterior corneal surface;Diopters;Change in mean corneal curvature;UCVA ( Uncorrected Visual Acuity );Corneal ablation ratio (ablation depth / central corneal thickness);BCVA (Best Corrected Visual Acuity);

Countries

China

Contacts

Public ContactGuofu Chen

Hangzhou Xihu Zhijiang Eye Hospital

314031818@qq.com+86 571 87670368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026